Mass tort litigation reflects society’s response to industries whose products cause widespread harm. Asbestos once dominated the courts, leading to decades of lawsuits and billions in compensation. Today, PFAS chemicals are emerging as the next major wave of litigation. But asbestos and PFAS are not alone. Tobacco, opioids, and environmental contamination cases also illustrate how litigation reshapes accountability. Revisiting these histories helps us understand the trajectory of mass torts and anticipate future challenges.

Asbestos: The Benchmark for Industrial Harm

Asbestos litigation began in the mid‑20th century, when workers exposed to asbestos fibers developed mesothelioma, lung cancer, and other diseases. Courts eventually recognized the link between asbestos exposure and illness, leading to thousands of lawsuits. Companies faced massive liabilities, and asbestos became synonymous with industrial negligence.

The scale of asbestos litigation was unprecedented. Insurers, manufacturers, and employers all faced claims, reshaping corporate accountability. Even today, asbestos cases remain active, decades after exposure risks were first identified.

PFAS: The Emerging Chemical Crisis

PFAS, or per‑ and polyfluoroalkyl substances, are synthetic chemicals used in products ranging from firefighting foam to non‑stick cookware. Known as “forever chemicals” because they do not break down easily, PFAS accumulate in the environment and human bodies. Studies link PFAS exposure to cancer, thyroid disease, and immune system disorders.

PFAS lawsuits are proliferating as communities discover contaminated water supplies and individuals face health consequences. Regulators in the United States and Europe are designating PFAS as hazardous substances, strengthening the legal basis for claims. The litigation is expanding rapidly, with municipalities, states, and individuals seeking damages for cleanup costs, medical expenses, and long‑term monitoring.

Tobacco: Corporate Deception and Public Health

Tobacco litigation remains one of the most influential mass torts in modern history. Beginning in the 1950s and culminating in the 1998 Master Settlement Agreement, lawsuits against cigarette manufacturers exposed decades of deception. Internal documents revealed that companies knew about health risks yet concealed them.

The Master Settlement Agreement forced tobacco companies to pay billions to states, restricted advertising, and funded anti‑smoking campaigns. Tobacco litigation reshaped public health policy and demonstrated how coordinated lawsuits could hold powerful industries accountable.

Opioids: The Modern Public Health Crisis

Opioid litigation represents another defining mass tort. Pharmaceutical companies faced lawsuits for aggressively marketing addictive painkillers while downplaying risks. States, municipalities, and individuals sued to recover healthcare costs and address community devastation.

Settlements have reached billions of dollars, funding treatment programs and prevention initiatives. Opioid litigation highlights how mass torts can respond to ongoing public health emergencies, balancing compensation with systemic reform.

Environmental Contamination: Lead Paint and Beyond

Lead paint litigation illustrates how environmental hazards become mass torts. Companies faced lawsuits for marketing products that caused developmental harm in children. Courts recognized corporate responsibility, leading to compensation and cleanup programs.

Other environmental cases, such as groundwater contamination and industrial pollution, continue to expand the scope of mass torts. These cases emphasize the importance of environmental justice and community‑wide accountability.

Comparing Asbestos and PFAS

While asbestos and PFAS differ in exposure patterns, they share key similarities. Both involve industries that concealed risks, both require complex scientific evidence, and both reshape corporate accountability.

• Scale of exposure: Asbestos was largely occupational, while PFAS affects entire communities.
• Health risks: Asbestos causes specific diseases, while PFAS is linked to multiple conditions.
• Evidence challenges: Both required evolving science to establish causation.
• Corporate accountability: Internal documents revealed knowledge of risks in both cases.

PFAS litigation may surpass asbestos in scale, given its widespread environmental persistence.

Insurance and Financial Impact

Asbestos litigation devastated insurers, who faced decades of claims. PFAS lawsuits may have similar consequences, as insurers struggle to cover long‑term liabilities. Analysts warn that PFAS could become the “next asbestos” in terms of financial impact, reshaping how insurers assess risk and how companies manage coverage for chemical products.

Regulatory Response

Governments eventually banned or restricted asbestos use, though litigation continued for decades. PFAS regulators are moving faster, designating PFAS as hazardous substances and setting stricter limits on contamination. Tobacco and opioid cases also show how regulation and litigation can work together, combining preventive measures with compensation structures.

Public Awareness

Mass torts educate the public about risks and reshape consumer behavior. Asbestos litigation raised awareness about workplace safety. Tobacco litigation exposed corporate deception. Opioid litigation highlighted the dangers of aggressive pharmaceutical marketing. PFAS litigation is raising awareness about chemical contamination and environmental justice.

Asbestos litigation continues decades after exposure risks were identified. Tobacco cases reshaped public health policy. Opioid settlements are funding treatment programs. PFAS litigation is just beginning, but experts predict it will last for generations. The persistence of PFAS in the environment ensures ongoing claims, making it a defining mass tort of the 21st century.

From asbestos to PFAS, mass tort litigation reflects how industries and courts respond to widespread harm. Asbestos set the precedent for accountability, while PFAS lawsuits represent the next frontier in environmental and health litigation. Tobacco and opioid cases demonstrate how litigation can reshape public health policy, while environmental contamination cases highlight community‑wide accountability. Together, these histories show that mass torts are not isolated events but part of a continuum of legal responses to industrial harm.